Similis Bio Strikes Again, Penning Deal With Chicago’s Novel351k
JSR Life Sciences Affiliate Recently Partnered With Brazil’s Blau
Less than a year after its inception, Simis Bio has found another partner for biosimilar development and planned commercialization.
You may also be interested in...
Deal Watch: Moderna, ElevateBio Subsidiary To Combine mRNA With Gene Editing
Moderna and Life Edit will team up to develop transformative or curative therapies for challenging genetic diseases. Erytech and Pherecydes unveil plan to merge and extend runway into 2024.
Similis Bio And Blau To Co-Develop Four Biosimilars For The Americas
JSR Life Science’s new business unit embarks on its first partnership with publicly listed Brazilian pharmaceutical.
Dr Reddy’s Can Still Go It Alone After Penning Orencia Biosimilar Deal
Targeting a dual biologic for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis, Coya Therapeutics has joined forces with abatacept biosimilar developer Dr Reddy’s.